Average Co-Inventor Count = 4.60
ph-index = 28
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (216 from 665 patents)
2. Incyte Holdings Corporation (41 from 147 patents)
3. Bristol-myers Squibb Pharma Company (4 from 234 patents)
4. Incyte Incorporation (1 from 4 patents)
221 patents:
1. 12466815 - Carboxamide compounds and uses thereof
2. 12466822 - Heterocyclic compounds as immunomodulators
3. 12441742 - Naphthyridine compounds as inhibitors of KRAS
4. 12441731 - Pyrazolopyrimidine compounds and uses thereof
5. 12441727 - Tricyclic compounds as inhibitors of KRAS
6. 12428420 - Tricyclic heterocycles as FGFR inhibitors
7. 12384778 - Pyrazolopyridine compounds and uses thereof
8. 12378243 - Quinoline compounds as inhibitors of KRAS
9. 12331063 - Hetero-bicyclic inhibitors of KRAS
10. 12312331 - Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
11. 12247026 - Heterocyclic compounds as immunomodulators
12. 12247038 - Pyrido[3,2-d]pyrimidine compounds as immunomodulators
13. 12201636 - Heterocyclylamines as PI3K inhibitors
14. 12187743 - Heterocyclic compounds as immunomodulators
15. 12187725 - Tricyclic urea compounds as JAK2 V617F inhibitors